Genmab — December 2017

[E_L]

not much on M&A indeed JV. Then again, they never reveal anything on that sort of question...

[OHW]

altså, den der forventer indikation i solide nu ved ASH, vil blive skuffede?

[StockBull]

2% op 118

[StockBull]

8

[E_L]

i don't expect anything on solids at ASH, do you? Maybe some comments at the R&D day, but no data

[Legolas23]

Eftersom solide ikke præsenteres på ASH, så har du ret

[rex_pacis]

I read somewhere that the first data from solids will come autumn-18

[Legolas23]

Se, hvad ASH er forkortelsen af. R&D efterfølgende kan måske afsløre, hvilke måneder i 2018, hvor vi kan blive klogere på Darzalex i solide.

[JohnW]

Hvad lægger I i hans ordvalg "we don't have proof of concept there" ?

[OHW]

De unævnlige startede med netto køb men er nu tilbage, hvor vi kender dem. Nettosalget fortsætter.

[E_L]

onclive video
http://www.onclive.com/inside-oncology/pre-conference-heme2017/daratumumab-for-smoldering-myeloma - http://www.onclive.com/inside-oncology/pre-conference-heme2017/phase-3-data-for-relapsed-refractory-myeloma

[E_L]

John - that he thinks it is too early to judge, there is no proof yet that it will work. which is correct, until we see data.

[rex_pacis]

American Society of Hematology

[JohnW]

@E L so no proof that it doesn't work either.

[Mcjean]

Ty EL i have and account there but cant remember password and a bit lazy:-)

[E_L]

exactly! and there are clearly INDICATIONS that it will work, but it needs to go through the process...

[E_L]

lol Mcjean, ok then so I need to do the work for you???

[Mcjean]

Need more coffee .......yep u do:-)

[E_L]

haha

[Mcjean]

But didnt expect you to make a slidesshow or posters.........very impressive indeed